DEXMEDETOMIDINE HYDROCHLORIDE (Page 7 of 7)

17 PATIENT COUNSELING INFORMATION

Dexmedetomidine hydrochloride in 0.9% Sodium Chloride injection is indicated for short-term intravenous sedation. Dosage must be individualized and titrated to the desired clinical effect. Blood pressure, heart rate and oxygen levels will be monitored both continuously during the infusion of dexmedetomidine hydrochloride in 0.9% Sodium Chloride injection and as clinically appropriate after discontinuation.

  • When dexmedetomidine hydrochloride in 0.9% Sodium Chloride injection is infused for more than 6 hours, patients should be informed to report nervousness, agitation, and headaches that may occur for up to 48 hours.
  • Additionally, patients should be informed to report symptoms that may occur within 48 hours after the administration of dexmedetomidine hydrochloride in 0.9% Sodium Chloride injection such as: weakness, confusion, excessive sweating, weight loss, abdominal pain, salt cravings, diarrhea, constipation, dizziness or light-headedness.

Manufactured for:

Slayback Pharma LLC,

Princeton, NJ 08540.

Manufactured at:

Corden Pharma S.p.A,

Caponago, Italy.

Revised: 12/2019

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

20 mL VIAL LABEL
NDC 71225-126-01
Single-dose vial. Discard unused portion.
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
80 mcg/20 mL
(4 mcg/mL)
For Intravenous Infusion Rx Only

Dexmed 20ml vial Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 20 mL CARTON LABEL
10 x 20 mL Single-Dose vial
NDC 71225-126-04
Single-dose vial. Discard unused portion.
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
80 mcg/20 mL
(4 mcg/mL)
For Intravenous Infusion Rx Only

Dexmed 20 mL Carton label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 50 mL BOTTLE LABEL
NDC 71225-126-02
Single-dose bottle. Discard unused portion.
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
200 mcg/50 mL
(4 mcg/mL)
For Intravenous Infusion Rx Only

Dexmed 50mL Container Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 50 mL CARTON LABEL
20 Units x 50 mL
NDC 71225-126-05
Single-dose bottle. Discard unused portion.
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
200 mcg/50 mL
(4 mcg/mL)
For Intravenous Infusion Rx Only

Dexmed 50 mL Carton label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 100 mL BOTTLE LABEL
NDC 71225-126-03
Single-dose bottle. Discard unused portion.
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
400 mcg/100 mL
(4 mcg/mL)
For Intravenous Infusion Rx Only

Dexmed 100mL container label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 100 mL CARTON LABEL
10 Units x 100 mL
NDC 71225-126-06
Single-dose bottle. Discard unused portion.
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
400 mcg/100 mL
(4 mcg/mL)
For Intravenous Infusion Rx Only

Dexmed 100mL Carton label
(click image for full-size original)
DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:71225-126
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DEXMEDETOMIDINE HYDROCHLORIDE (DEXMEDETOMIDINE) DEXMEDETOMIDINE 4 ug in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE 9 mg in 1 mL
METHIONINE 1 mg in 1 mL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:71225-126-05 20 BOTTLE in 1 CARTON contains a BOTTLE (71225-126-02)
1 NDC:71225-126-02 50 mL in 1 BOTTLE This package is contained within the CARTON (71225-126-05)
2 NDC:71225-126-06 10 BOTTLE in 1 CARTON contains a BOTTLE (71225-126-03)
2 NDC:71225-126-03 100 mL in 1 BOTTLE This package is contained within the CARTON (71225-126-06)
3 NDC:71225-126-04 10 VIAL in 1 CARTON contains a VIAL (71225-126-01)
3 NDC:71225-126-01 20 mL in 1 VIAL This package is contained within the CARTON (71225-126-04)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA212791 12/06/2019
Labeler — Slayback Pharma LLC (967770848)
Establishment
Name Address ID/FEI Operations
Corden Pharma SpA 338725627 ANALYSIS (71225-126), LABEL (71225-126), MANUFACTURE (71225-126), PACK (71225-126)

Revised: 05/2020 Slayback Pharma LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.